Development of validated stability-indicating assay methods--critical review.

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Drug Development

Background:

• Validated stability-indicating assay methods (SIAMs) are essential for assessing drug product shelf-life.
• Existing methods often have shortcomings regarding regulatory compliance.
• Ensuring drug substance and product integrity requires reliable analytical techniques.

Purpose of the Study:

• To review the development of validated SIAMs for drug substances and products.
• To identify and address shortcomings of current methods concerning regulatory requirements.
• To provide a systematic approach for developing robust SIAMs.

Main Methods:

• Review of literature on SIAM development.
• Analysis of regulatory requirements for analytical methods.
• Discussion of critical aspects in SIAM development, including degradation product separation and mass balance.
• Evaluation of stress testing and methods for combination products.

Main Results:

• Shortcomings of reported SIAMs in meeting regulatory standards were identified.
• A systematic development approach for SIAMs was discussed.
• Key challenges such as separation of degradation products, mass balance, and stress testing were addressed.
• Applicability of pharmacopoeial methods and SIAM requirements for biotechnological products were considered.

Conclusions:

• Robust and validated SIAMs are critical for regulatory compliance in drug development.
• A systematic approach is necessary to overcome challenges in SIAM development.
• Further attention is needed for SIAMs in complex formulations like combination products and biotechnological substances.